SI-BONE Inc. Common Stock (SIBN)
Stock · NASDAQ · Health Care
$19.68as of 10/16/2026
Price chart
Active signals
SIBN Signal Track Record
How signals performed across all stocks →What SIBN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 38 | +1.6% | 53% | September 2, 2026 |
| Bollinger Band Breakout | 20 | +0.7% | 50% | October 5, 2026 |
| Bollinger Band Breakdown | 19 | -4.4% | 37% | April 29, 2026 |
| 200-Day Moving Average TouchActive now | 15 | -10.3% | 33% | June 18, 2026 |
| Any 20-session window (baseline) | +0.5% | 51% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SIBN
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triang…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 376
- Website
- si-bone.com/
Fundamentals
- 1-day range
- $19.19$19.99
- Market cap
- $813.01M
- P/E (trailing)
- —
- P/E (forward)
- -59.49
- EPS (trailing)
- $-0.33
- Dividend yield
- —
- Beta
- 0.65
- Avg. volume
- 554.7K
How SI-BONE Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub
Forecasts
9 analyst ratings
SI-BONE Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SIBNSI-BONE Inc. Common Stock$19.68▼ 1.16%Market cap $813.01MP/E —$11.48$21.89
- SGPSpyGlass Pharma Inc. Common Stock$24▼ 2.91%Market cap $827.48MP/E —$17.06$32.44
- SSIISS Innovations International Inc. Common Stock$2.53▼ 1.94%Market cap $742.49MP/E —$2.57$10
- TCMDTactile Systems Technology Inc. Common Stock$22.52▼ 3.31%Market cap $650.97MP/E 21.02$14.43$37.77
- BBNXBeta Bionics Inc. Common Stock$16.35▼ 5.55%Market cap $634.80MP/E —$8.8$32.71
- BWAYBrainsWay Ltd. American Depositary Shares$11.44▼ 3.21%Market cap $626.52MP/E 53.55$2,391$5,123
- ANGOAngioDynamics Inc. Common Stock$11.24▼ 2.94%Market cap $624.53MP/E —$9.39$16.29
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SIBN SI-BONE Inc. Common Stock | $813.01M | — | $19.68 | ▼ 1.16% | $11.48$21.89 |
| SGP SpyGlass Pharma Inc. Common Stock | $827.48M | — | $24 | ▼ 2.91% | $17.06$32.44 |
| SSII SS Innovations International Inc. Common Stock | $742.49M | — | $2.53 | ▼ 1.94% | $2.57$10 |
| TCMD Tactile Systems Technology Inc. Common Stock | $650.97M | 21.02 | $22.52 | ▼ 3.31% | $14.43$37.77 |
| BBNX Beta Bionics Inc. Common Stock | $634.80M | — | $16.35 | ▼ 5.55% | $8.8$32.71 |
| BWAY BrainsWay Ltd. American Depositary Shares | $626.52M | 53.55 | $11.44 | ▼ 3.21% | $2,391$5,123 |
| ANGO AngioDynamics Inc. Common Stock | $624.53M | — | $11.24 | ▼ 2.94% | $9.39$16.29 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Truist Securities Maintains Buy on SI-BONE, Raises Price Target to $25benzinga · 10/14/2026
Insider Activity
Insider Actions →- DUNN JEFFREY W · August 3, 2026 · Option Exercise20.0K @ $4.68
- DUNN JEFFREY W · August 3, 2026 · Sale20.0K @ $18.46
- Maheshwari Anshul · July 2, 2026 · Sale1.6K @ $16.73
- Maheshwari Anshul · July 2, 2026 · Sale1.8K @ $16.8
- PISETSKY MICHAEL A. · July 2, 2026 · Sale1.3K @ $16.73
- PISETSKY MICHAEL A. · July 2, 2026 · Sale34 @ $16.86
- PISETSKY MICHAEL A. · July 2, 2026 · Sale1.8K @ $16.7
- DUNN JEFFREY W · June 5, 2026 · Sale3.6K @ $15.25
- Jeryl L. Hilleman · June 4, 2026 · Grant11.0K
- Nishimura Mika · June 4, 2026 · Grant11.0K
- Thomas A. West · June 4, 2026 · Grant11.0K
- Davis Timothy E JR · June 4, 2026 · Grant11.0K
- John Gordon Freund · June 4, 2026 · Grant11.0K
- DUNN JEFFREY W · June 4, 2026 · Grant11.0K
- Davis Timothy E JR · May 29, 2026 · Sale3.5K @ $14.14
Institutional Ownership
March 31, 2026
- Total shares held
- 42.92M
- Total value held
- $532.60M
- Institutional holders
- 172
- Unknown5.35M
- Unknown3.43M
- Unknown2.51M
- Unknown2.12M
- Unknown1.89M
- Unknown1.76M
- Unknown1.74M
- Unknown1.43M
- Unknown1.29M
- Unknown1.24M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Truist Securities raises SI-BONE price target to $25
Truist Securities kept its existing rating on SI‑BONE and lifted its price target to $25. The new target sits near the midpoint of the nine‑analyst consensus range of $20 to $32, and slightly above the current 52‑week high of $21.89. This adjustment suggests the firm sees further upside potential for the company.
Truist Securities raises SI-BONE price target to $25. Truist Securities kept its existing rating on SI‑BONE and lifted its price target to $25. The new target sits near the midpoint of the nine‑analyst consensus range of $20 to $32, and slightly above the current 52‑week high of $21.89. This adjustment suggests the firm sees further upside potential for the company.